Safety and efficacy of intraoperative 5-fluorouracil infiltration in pterygium treatment

被引:14
|
作者
Valezi, Vanessa Grandi [1 ]
Schellini, Silvana Artioli [1 ]
Hata Viveiros, Magda Massae [1 ]
Padovani, Carlos Roberto [1 ]
机构
[1] UNESP, Fac Med Botucatu, DEP OFT ORL CCP, BR-18618000 Botucatu, SP, Brazil
关键词
Pterygium; Fluorouracil; Mitomycin/administration & dosage; Chemotherapy adjuvant; Antimitotic agents; Evaluation of the efficacy-effectiveness of interventions; Intraoperative care; Recurrence/prevention & control; TOPICAL MITOMYCIN-C; PREVENTION; SURGERY;
D O I
10.1590/S0004-27492009000200007
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the safety and efficacy of intraoperative infiltration of 5-fluorouracil (5-FU) as an adjuvant drug in pterygium treatment. Methods: Of 125 consecutive patients, 125 eyes with primary and recurrent pterygium underwent pterygium excision with intraoperative 5-FU (25 mg/mL) infiltration. The superior and inferior conjunctiva was approximated to cover the scleral bed and 0.2 mL 5-FU was injected at the end of the surgical procedure. The gender, occupation, pterygium characteristics and the follow-up at 7, 21, 60 e 180 days after surgery were evaluated and the data were statistically analyzed. Results: With follow-up of 180 days the patients had no serious complications observed during or after surgery. The relapse rate was 35.8% and occurred in primary (35.7%) and recurrent (36.4%) lesions with no statistical difference. Conclusions: This study suggests that intraoperative infiltration of 5-FU is safe. However the high recurrence rate indicated that other studies would be necessary to show the concentration/dose to better prevent it.
引用
收藏
页码:169 / 173
页数:5
相关论文
共 50 条
  • [41] Anticancer efficacy in vivo and in vitro, synergy with 5-fluorouracil, and safety of recombinant methioninase
    Yoshioka, T
    Wada, T
    Uchida, N
    Maki, H
    Yoshida, H
    Ide, N
    Kasai, H
    Hojo, K
    Shono, K
    Maekawa, R
    Yagi, S
    Hoffman, RM
    Sugita, K
    CANCER RESEARCH, 1998, 58 (12) : 2583 - 2587
  • [42] Phase III multicenter randomized clinical trial to evaluate the safety and efficacy of CoFactor®/5-fluorouracil/bevacizumab versus leucovorin/5-fluorouracil/bevacizumab as initial treatment for metastatic colorectal carcinoma
    Saif, Muhammad Wasif
    Merritt, James
    Robbins, Joan
    Stewart, Jeffrey
    Schupp, Joachim
    CLINICAL COLORECTAL CANCER, 2006, 6 (03) : 229 - 234
  • [43] Clinical efficacy of 5-fluorouracil (5-FU) topical cream for treatment of cholesteatoma
    Takahashi, H
    Funabiki, K
    Hasebe, S
    Fukuda-Yamamoto, T
    Kaieda, S
    Iwanaga, T
    Kumagami, H
    Takasaki, K
    AURIS NASUS LARYNX, 2005, 32 (04) : 353 - 357
  • [44] Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil
    van Kuilenburg, ABP
    EUROPEAN JOURNAL OF CANCER, 2004, 40 (07) : 939 - 950
  • [45] Clinical Efficacy of 5-Fluorouracil and Bleomycin in Dermatology
    Kim, Suyeon
    Woo, Yu Ri
    Cho, Sang Hyun
    Lee, Jeong Deuk
    Kim, Hei Sung
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (02)
  • [46] 5-fluorouracil vs. beta-irradiation in the prevention of pterygium recurrence
    Bekibele, CO
    Baiyeroju, AM
    Ajayi, BGK
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2004, 58 (10) : 920 - 923
  • [47] 5-FLUOROURACIL IN TREATMENT OF GASTROINTESTINAL NEOPLASIA
    OBERFIELD, RA
    CADY, B
    WATKINS, E
    NEW ENGLAND JOURNAL OF MEDICINE, 1973, 288 (17): : 911 - 912
  • [48] TREATMENT OF PLANTAR WARTS WITH 5-FLUOROURACIL
    BUNNEY, MH
    BRITISH JOURNAL OF DERMATOLOGY, 1973, 89 (01) : 96 - 97
  • [49] Use of 5-Fluorouracil in Chalazion Treatment
    Moran, Joshua Michael
    Mohadjer, Yasaman
    Zakieh, Abdel-Rahman
    Shiloach, Mira
    Macsai, Marian
    Phelps, Paul
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (07)
  • [50] Pterygium recurrence following preoperative topical Mitomycin C and 5-Fluorouracil eyedrops
    Rajagopal, J.
    Das, G. K.
    Sharma, S.
    Sahu, P. K.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2024, 47 (09):